Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.42 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.42 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | EDNRB | P24530 | 1/20 | 0.36 |
| ▸ | EDNRA | P25101 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27777776 | 0.83 | POLB (0.53) | POLBHDAC3HDAC6HDAC4HDAC7 | |
| SCHEMBL28897874 | 0.82 | POLB (0.42) | POLBHDAC3HDAC6HDAC4HDAC7 | |
| SCHEMBL20917779 | 0.81 | POLB (0.52) | POLBHDAC3HDAC6HDAC4HDAC7 | |
| SCHEMBL7596802 | 0.81 | POLB (0.52) | POLBHDAC3HDAC6HDAC4HDAC7 | |
| SCHEMBL4402923 | 0.79 | POLB (0.71) | POLBHDAC3HDAC6HDAC4HDAC7 | |
| SCHEMBL30341829 | 0.79 | POLB (0.71) | POLBHDAC3HDAC6HDAC4HDAC7 | |
| SCHEMBL7532314 | 0.79 | POLB (0.50) | POLBHDAC3HDAC6HDAC4HDAC7 | |
| SCHEMBL643958 | 0.79 | POLB (0.50) | POLBHDAC3HDAC6HDAC4HDAC7 | |
| SCHEMBL21778856 | 0.79 | POLB (0.46) | POLBHDAC3HDAC6HDAC4HDAC7 | |
| SCHEMBL7837312 | 0.79 | ATM (0.50) | HDAC3HDAC6HDAC4HDAC7HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113292456-B | Preparation method of N-fluorenylmethoxycarbonyl-L-aspartic acid-4-tert-butyl ester | 常州吉恩药业有限公司 | 2022-04-29 | — | — | CN | claimed |
| CN-113292456-A | Preparation method of N-fluorenylmethoxycarbonyl-L-aspartic acid-4-tert-butyl ester | 常州吉恩药业有限公司 | 2021-08-24 | — | — | CN | claimed |
| WO-2014031204-A2 | CARBOHYDRATE-SELECTIVE RECEPTORS | NEW YORK UNIVERSITY (US) | 2014-02-27 | — | — | WO | claimed |
| CN-102438453-A | Plant growth regulator additive | TAMINCO NV | 2012-05-02 | — | — | CN | claimed |
| WO-2026103740-A1 | CEACAM5-ANTIGEN-TARGETING ANTIBODY, ANTIBODY-DRUG CONJUGATE THEREOF AND USE THEREOF | 信达生物医药科技(杭州)有限公司 | 2026-05-21 | — | — | WO | disclosed |
| CN-116375706-B | Abamectin sodium key intermediate and preparation method thereof | 时森海(杭州)医药科技有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-118903456-A | Ligand-drug conjugate of irinotecan analogue, preparation method and application thereof | 江苏恒瑞医药股份有限公司 | 2024-11-08 | — | — | CN | disclosed |
| CN-118806924-A | Ligand-drug conjugate of irinotecan analogue, preparation method and application thereof | 江苏恒瑞医药股份有限公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-112512591-B | Ligand-drug conjugate of irinotecan analogue, preparation method and application thereof | 江苏恒瑞医药股份有限公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-118382620-A | Novel compounds for degrading target proteins or polypeptides by multiple ubiquitination | 普瑞泽治疗公司 | 2024-07-23 | — | — | CN | disclosed |
| CN-117384078-A | Novel polymer, diamine compound, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | 日产化学株式会社 | 2024-01-12 | — | — | CN | disclosed |
| CN-117384077-A | Novel polymer, diamine compound, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | 日产化学株式会社 | 2024-01-12 | — | — | CN | disclosed |
| EP-0641354-A4 | OLIGONUCLEOTIDES HAVING AMINOHYDROCARBON PHOSPHONATE MOIETIES. | PHARMAGENICS INC (US) | 1996-01-10 | — | — | EP | disclosed |
| WO-1995031572-A1 | AMINOHYDROCARBON PHOSPHONATE OLIGONUCLEOTIDES AND USES THEREFOR | PHARMGENICS, INC. (US) | 1995-11-23 | — | — | WO | disclosed |
| EP-0673388-A1 | DOUBLE CHAIN PEPTIDE COMPOUNDS HAVING HEMOREGULATORY ACTIVITY | NYCOMED IMAGING AS (NO) | 1995-09-27 | — | — | EP | disclosed |
| EP-0643725-A1 | SINGLE CHAIN PEPTIDE COMPOUNDS HAVING HEMOREGULATORY ACTIVITY | NYCOMED IMAGING AS (NO) | 1995-03-22 | — | — | EP | disclosed |
| EP-0641354-A1 | OLIGONUCLEOTIDES HAVING AMINOHYDROCARBON PHOSPHONATE MOIETIES | PHARMAGENICS, INC. (US) | 1995-03-08 | — | — | EP | disclosed |
| WO-1993024524-A1 | SINGLE CHAIN PEPTIDE COMPOUNDS HAVING HEMOREGULATORY ACTIVITY | HAFSLUND NYCOMED AS (NO) | 1993-12-09 | — | — | WO | disclosed |
| EP-0569802-A1 | Arylacetamides | MERCK PATENT GmbH (DE) | 1993-11-18 | — | — | EP | disclosed |
| WO-1993011148-A1 | OLIGONUCLEOTIDES HAVING AMINOHYDROCARBON PHOSPHONATE MOIETIES | PHARMAGENICS, INC. (US) | 1993-06-10 | — | — | WO | disclosed |